Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Haematologica
Prif Awduron: Kornauth, Christoph, Herbaux, Charles, Boidol, Bernd, Guillemette, Chantal, Caron, Patrick, Mayerhöfer, Marius E., Poulain, Stéphanie, Tournilhac, Olivier, Pemovska, Tea, Chong, Stephen J.F., van der Kouwe, Emiel, Kazianka, Lukas, Hopfinger, Georg, Heintel, Daniel, Jäger, Roland, Raderer, Markus, Jäger, Ulrich, Simonitsch-Klupp, Ingrid, Sperr, Wolfgang R., Kubicek, Stefan, Davids, Matthew S., Staber, Philipp B.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Fondazione Ferrata Storti 2021
Pynciau:
Letters to the Editor
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8327744/
https://ncbi.nlm.nih.gov/pubmed/33626863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2020.271304
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg